603087.SS
Price:
$55.49
Market Cap:
$32.81B
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Industry
Medical - Instruments & Supplies
IPO Date
2020-06-29
Stock Exchange
SHH
Ticker
603087.SS
According to Gan & Lee Pharmaceuticals.’s latest financial reports and current stock price. The company's current Current Ratio is 4.92. This represents a change of -24.30% compared to the average of 6.50 of the last 4 quarters.
The mean historical Current Ratio of Gan & Lee Pharmaceuticals. over the last ten years is 7.73. The current 4.92 Current Ratio has changed 6.26% with respect to the historical average. Over the past ten years (40 quarters), 603087.SS's Current Ratio was at its highest in in the March 2021 quarter at 18.90. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
7.73
Median
6.84
Minimum
4.51
Maximum
14.54
Discovering the peaks and valleys of Gan & Lee Pharmaceuticals. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 114.24%
Maximum Annual Current Ratio = 14.54
Minimum Annual Increase = -50.77%
Minimum Annual Current Ratio = 4.51
Year | Current Ratio | Change |
---|---|---|
2024 | 4.73 | -40.74% |
2023 | 7.98 | 14.61% |
2022 | 6.97 | -50.77% |
2021 | 14.15 | -2.69% |
2020 | 14.54 | 114.24% |
2019 | 6.79 | -1.61% |
2018 | 6.90 | 17.57% |
2017 | 5.87 | 21.16% |
2016 | 4.84 | 7.43% |
2015 | 4.51 | -3.67% |
The current Current Ratio of Gan & Lee Pharmaceuticals. (603087.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.56
5-year avg
9.67
10-year avg
7.73
Gan & Lee Pharmaceuticals.’s Current Ratio is greater than Guangzhou Kingmed Diagnostics Group Co., Ltd. (3.18), greater than Gongniu Group Co., Ltd. (3.71), greater than WuXi AppTec Co., Ltd. (2.29), greater than Topchoice Medical Corporation (1.61), greater than Hangzhou Tigermed Consulting Co., Ltd. (1.62),
Company | Current Ratio | Market cap |
---|---|---|
3.18 | $13.00B | |
3.71 | $84.93B | |
2.29 | $205.00B | |
1.61 | $18.73B | |
1.62 | $43.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gan & Lee Pharmaceuticals. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gan & Lee Pharmaceuticals. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Gan & Lee Pharmaceuticals.'s Current Ratio?
How is the Current Ratio calculated for Gan & Lee Pharmaceuticals. (603087.SS)?
What is the highest Current Ratio for Gan & Lee Pharmaceuticals. (603087.SS)?
What is the 3-year average Current Ratio for Gan & Lee Pharmaceuticals. (603087.SS)?
What is the 5-year average Current Ratio for Gan & Lee Pharmaceuticals. (603087.SS)?
How does the current Current Ratio for Gan & Lee Pharmaceuticals. (603087.SS) compare to its historical average?